Small Intestine Neuroendocrine Tumours: “No other cancer really looks like this”


It’s known that Neuroendocrine Cancer is quite different in many ways from other cancers, notwithstanding the misnomer term carcinoid which is thankfully being slowly moved out of terminology.  As a few examples:

  • It’s a wide spectrum heterogeneous cancer group with indolent isolated small tumours at one end all the way across to extremely aggressive metastatic cases at the other end.
  • It’s a cancer type that can be syndromically functional or non-functional to add to diagnostic and management challenges.
  • It’s a cancer that can appear almost anywhere in the human body.

One of it’s less well-known traits is the ability to produce multiple primary tumours.  Most people might be thinking of Multiple Endocrine Neoplasia at this point (a syndrome that predisposes the patient to multiple primary tumours in different organs).  However, I also mean multi-focal (multicentric), i.e. more than one primary in the same organ.  And that is the focus of this post in regards Small Intestine NETs where this is a common occurrence (one Swedish study put that at 40%).   

This new study from Sweden has appeared twice in the last month, one giving a highly technical summary of the genome mapping to a small group of tumours. The other gives a higher-level summary.  

The conclusion from this small study is astonishing in that it would appear multifocal primary NETs in the small intestine are capable of producing their own metastases.  I personally don’t believe that changes anything in terms of therapy, but it does reinforce the need for a full check during surgery, something known in surgical terms as “running the bowel” which can be done for different reasons depending on the scenario but in cases of small intestine NETs is important as many of these cases can have multifocal tumours (multiple primaries).  

See the abstract below:

Let’s start with the overview as that is what most of you will be looking for.  There’s also some technical stuff in this overview but genome mapping is a highly technical subject not understood by many.

Concrete clinical question 

“When we remove neuroendocrine tumors in the small intestine, we often find many tumors in the same place, which is unusual. No other cancer really looks like this,” says Erik Elias, an endocrine surgeon at Sahlgrenska University Hospital and a post-doctoral researcher at the University of Gothenburg. “The cancer is also unusual because known driver mutations are largely absent.”

Surprising answer

“The result was both unambiguous and surprising. The intestinal tumors had developed independently. Yet the metastases were clearly related and could be traced back to a specific bowel tumor.”

Erik Elias and Erik Larsson Lekholm in fornt of hospital.
Erik Elias and Erik Larsson Lekholm. Photo: Elin Lindström

Multiple tumors without kinship occur simultaneously in the small intestine | University of Gothenburg (

Citing information:

Elias, E., Ardalan, A., Lindberg, M. et al. Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine. Nat Commun 12, 6367 (2021).

Click this link to read full article:

Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine | Nature Communications

Click picture to read more


I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.  Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional as they are not members of the private group or followers of my sites in any official capacity.  Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.

Subscribe to my newsletter

Thanks for reading.


I’m also active on Facebook. Like my page for even more news. Help me build up my new site here – click here and ‘Like’

Sign up for my newsletters – Click Here


My Diagnosis and Treatment History

Follow me on twitter

Check out my online presentations

Check out my WEGO Health Awards

Like my new awareness page – click here or on the photo.  (Like rather than follow please!)

Check out my Glossary of Terms – click here

patients included

Please Share this post for Neuroendocrine Cancer awareness and to help another patient


RonnyAllan.NET – Summary of January 2023 – Ronny Allan – Living with Neuroendocrine Cancer

Summary Great start to 2023 and I thank those who continue to support my social media and this blog.  I’m keen to hear any suggestions

Read More »

Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies (incl NET)

Trial Summary This interesting trial is a multi-cancer effort including NET.  The phase I clinical trial of Procaspase Activating Compound-1 (PAC-1), a drug that spurs

Read More »

Dustin Diamond

I’m behind the curve on this one after being ahead on celebrities such as Steve Jobs, Aretha Franklin, Wilko Johnson and Olivia Williams.  But in

Read More »

Neuroendocrine tumors are uncommon but definitely not rare

USA finally commits  UK and Australian figures recently confirmed that Neuroendocrine Cancer is the 10th and 7th most common cancer type.  It was great to

Read More »

Cancer Ablation

What is Cancer Ablation? This is a minimally invasive surgical method to treat solid cancers. Special probes are used to “burn” or “freeze” cancers. Computed

Read More »

Lactose intolerance – the NET Effect

Background   When I cast my mind back to my very first surgery, I remember asking my Oncologist what I could do to put on weight. 

Read More »

EUS Guided Ablation for small pancreatic NETs (Less than 2cm)

To burn or not to burn? I once wrote a post about Pancreatic NET “to cut or not to cut”.  You can read that here. 

Read More »

RonnyAllan.NET – a review of 2022

Review In 2022, my pet project (my blog) hit 2 million views in early November – that was a major boost.  It takes 3-4 years to get

Read More »

RonnyAllan.NET – Summary of December 2022

Summary December is always the quietest month of the year, no surprise why!  However, the top 10 below is somewhat surprising, I guess some posts

Read More »

3 thoughts on “Small Intestine Neuroendocrine Tumours: “No other cancer really looks like this”

  • I recall asking how many tumours were found in the Small Bowel. The surgeon replied there were too many to count but we removed the affected length plus a clear % at each end. The tumours had already metastasised to the liver, lymph node and the mesentery. What was fascinating was the primaries being G1 and the metastases at G2.

    • it would have been an interesting correlation, but I did note that there was even one patient where they spotted the same signature in different metastases from the same primary tumour!

    • Joani Wicklund

      Admittedly much of this was way over my head. I will say how grateful I was for an astute surgeon. I presented with a pretty typical NET on imaging, but when they got in there they also found a second tumor in the Ileum and the 3 multifocal mesenteric tumor deposits that were .03 cm, .08 cm, and 1 cm. The correlation between the two nets (Jejunum and Ileum which were completely separate) and the tumor deposits is confusing to me.

I love comments - feel free!

%d bloggers like this: